Kidney FNA - Clues and Pitfalls
Eva M. Wojcik, MD
Fine-needle aspiration (FNA) biopsy of the kidney has a non disputable role in the diagnosis and treatment of renal lesions. Particularly, resent improvements in renal imaging techniques have brought renal FNA to the forefront, since small and asymptomatic renal masses are increasingly being detected. Consequentially, there is a pressing need for accurate typing as well as grading of RCC which, in turn, will aid in selection of cases of nephron sparing surgeries, partial nephrectomies or even non-surgical measures like cryoablation. these therapeutic options are however not advisable for high-grade neoplasms. During this webinar we will review broad spectrum of renal FNAs including normal renal structures, inflammatory and reactive changes, cystic lesions and benign and malignant neoplasms. We will emphasize diagnostic clues and pitfalls.
This educational activity is designed for pathologists, cytopathologists, cytotechnologists, students and other members of the cytopathology community.
- Understand why kidney FNAs are challenging
- Recognize the indications and learn the potential complications of Renal FNAs
- Learn normal structures often seen in Renal FNAs
- Recognize diagnostic clues and pitfalls of solid and cystic renal lesions
- Apply appropriate ancillary tests in FNA and CB material
Current ACCME guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect the speaker’s presentation(s). Therefore, it is the policy of the ASC to insure balance, independence, objectivity, and scientific rigor in all its educational programs. All planning individuals participating in any ASC Educational Activity are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. Click here for a complete list.
Eva M. Wojcik, MD
The presenter has no conflicts of interest or financial relationships to disclose.
ACCREDITATION AND DESIGNATION STATEMENTS
Continuing Medical Education (CME) Statement
The American Society of Cytopathology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The American Society of Cytopathology designates this enduring educational activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Board of Pathology Maintenance of Certification (MOC)
This product can help fulfill the CME requirements and Self-Assessment Modules (SAMs) mandated by the American Board of Pathology Maintenance of Certification (MOC) process. Earn up to 2.0 SAM Credit Hours.
Continuing Medical Laboratory Education (CMLE)
The ASC designates this activity for a maximum of 2.0 Continuing Medical Laboratory Education (CMLE) credit hours for non-physicians. The CMLE credit hours meet the continuing education requirements for the ASCP Board of Registry Certification Maintenance Program. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Cytotechnologists with Licenses in Florida and California
This program is approved for 2 continuing education credits in the State of Florida and 1 in the State of California. The credit on each link is good for three years from the live presentation date.
- 2.00 AMA PRA Category 1 Credit™
- 1.00 California Credits
- 2.00 CMLE
- 2.00 Florida Credits
- 2.00 MOC II
- 2.00 Participant